1. A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of IV to Oral Omadacycline to Moxifloxacin for the Treatment of Adult Subjects with CABP (The OPTIC Study). (4th October 2017) Authors: Stets, Roman; Popescu, Monica; Gonong, Joven; Mitha, Ismail; Nseir, William; Madej, Andrzej; Kirsch, Courtney; Das, Anita; Garrity-Ryan, Lynne; Steenbergen, Judith N; Manley, Amy; Eckburg, Paul; Villano, Stephen; Tzanis, Evan; McGovern, Paul; Loh, Evan Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies. (4th October 2017) Authors: Darpo, Borje; Tzanis, Evan; Garrity-Ryan, Lynne; Manley, Amy; McGovern, Paul; Loh, Evan Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants. (22nd September 2016) Authors: Tzanis, Evan; Manley, Amy; Villano, Stephen; Tanaka, S. Ken; Bai, Stephen; Loh, Evan Journal: Journal of clinical pharmacology Issue: Volume 57:Number 3(2017) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections. (November 2016) Authors: Villano, Stephen; Steenbergen, Judith; Loh, Evan Journal: Future microbiology Issue: Volume 11:Number 11(2016:Nov.) Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗